BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8389574)

  • 1. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells.
    Couture LA; Lehman JM
    Int J Dev Biol; 1993 Mar; 37(1):125-33. PubMed ID: 8389574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trans-acting factor represses the activity of the polyoma virus enhancer in undifferentiated embryonal carcinoma cells.
    Sassone-Corsi P; Fromental C; Chambon P
    Oncogene Res; 1987 Jul; 1(2):113-9. PubMed ID: 2835729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors.
    Furukawa K; Yamaguchi Y; Ogawa E; Shigesada K; Satake M; Ito Y
    Cell Growth Differ; 1990 Mar; 1(3):135-47. PubMed ID: 1964077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of polyomavirus mutants multiadapted to murine embryonal carcinoma cells.
    Melin F; Pinon H; Kress C; Blangy D
    J Virol; 1985 Mar; 53(3):862-6. PubMed ID: 2983095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficiency DNA transfection in murine embryonal carcinoma cells: expression of pSV3neo in wild type and retinoid-resistant cell lines.
    Purpus EJ; McCue PA
    Int J Dev Biol; 1993 Mar; 37(1):117-24. PubMed ID: 8389573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host range specificity of polyomavirus EC mutants in mouse embryonal carcinoma and embryonal stem cells and preimplantation embryos.
    Mélin F; Kemler R; Kress C; Pinon H; Blangy D
    J Virol; 1991 Jun; 65(6):3029-43. PubMed ID: 1851869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature dependent expression of polyoma virus in murine embryonal carcinoma cells.
    Dandolo L; Vasseur M; Kress C; Aghion J; Blangy D
    J Cell Physiol; 1980 Oct; 105(1):17-24. PubMed ID: 6253510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells.
    Vasseur M; Kress C; Montreau N; Blangy D
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1068-72. PubMed ID: 6244578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common features of polyomavirus mutants selected on PCC4 embryonal carcinoma cells.
    Melin F; Pinon H; Reiss C; Kress C; Montreau N; Blangy D
    EMBO J; 1985 Jul; 4(7):1799-803. PubMed ID: 2992943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.
    Katinka M; Vasseur M; Montreau N; Yaniv M; Blangy D
    Nature; 1981 Apr; 290(5808):720-2. PubMed ID: 6261151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of the interaction of polyoma virus and simian virus 40 with embryonal carcinoma cells.
    Hales K; Lehman JM
    Exp Mol Pathol; 1987 Aug; 47(1):48-58. PubMed ID: 3038593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.
    Zhang S; Magnusson G
    J Virol; 2001 Nov; 75(21):10015-23. PubMed ID: 11581370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Ki-ras gene amplification and malignant behavior in murine embryonal carcinoma cell lines.
    Vilette D; Emanoil-Ravier R; Buffe D; Rimbaut C; Peries J
    Cancer Res; 1987 Feb; 47(3):867-73. PubMed ID: 3542196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.